Our Authors

Dr. Elena Vance is a distinguished research scientist with over two decades of experience in molecular biology and genomics. She earned her Ph.D. from MIT and completed postdoctoral research at the Broad Institute. Her work has been instrumental in advancing our understanding of gene editing technologies, particularly CRISPR-based systems. As the lead columnist for Frontier Science, Elena brings complex scientific breakthroughs to life, making cutting-edge research accessible to both professionals and curious minds alike.

Dr. Marcus Thorne is a seasoned clinical researcher with extensive experience in drug development and clinical trials. With an M.D. from Johns Hopkins and a Ph.D. in Pharmacology from Stanford, he has spent 25 years bridging the gap between laboratory discoveries and patient care. Marcus has led numerous Phase II and Phase III clinical trials for novel therapeutics and serves as a consultant for several pharmaceutical companies. His Therapeutics column provides in-depth analysis of emerging treatments and the science behind them.

Hiroshi Tanaka is a leading expert in medical technology and biomedical engineering. After earning his engineering degree from the University of Tokyo and an MBA from INSEAD, he spent a decade working with major medical device manufacturers in Japan and the United States. Hiroshi has been at the forefront of surgical robotics and diagnostic imaging innovations. His MedTech column offers comprehensive analyses of the latest medical devices, comparing technical specifications with real-world clinical outcomes.

Sarah Jenkins is a dynamic health technology analyst specializing in the intersection of healthcare and digital innovation. With a background in computer science from Carnegie Mellon and healthcare administration from Harvard, she brings a unique perspective to the rapidly evolving digital health landscape. Sarah has advised numerous health tech startups and established healthcare systems on digital transformation strategies. Her Digital Health column explores telemedicine, AI diagnostics, wearable technology, and the future of connected healthcare.

Alexander von Berg is a veteran industry analyst with nearly three decades of experience tracking the biotechnology and pharmaceutical sectors. After beginning his career as a research analyst at Goldman Sachs, he went on to lead healthcare equity research at several major investment banks. Alexander holds an MBA from Wharton and has been recognized as a top-ranked analyst by Institutional Investor. His Industry Radar column provides sharp insights into market trends, M&A activity, IPOs, and the business strategies shaping the future of biotech.

Dr. Clara Rossi is an internationally recognized microscopy specialist and scientific imaging expert. She earned her Ph.D. in Cell Biology from the Max Planck Institute and has pioneered several advanced imaging techniques. Clara has curated scientific image exhibitions at major museums and her work has been featured in Nature, Science, and National Geographic. As the curator of the Micro-Gallery column, she showcases the most stunning and scientifically significant microscopy images, revealing the hidden beauty of the biological world.